These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 11884044
1. The role of Tc99m-sestamibi scintimammography in combination with the triple assessment of primary breast cancer. Leidenius MH, Leppänen EA, Tykkä HT, von Smitten KA. Eur J Surg Oncol; 2002 Mar; 28(2):108-12. PubMed ID: 11884044 [Abstract] [Full Text] [Related]
2. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography. Gommans GM, van der Zant FM, van Dongen A, Boer RO, Teule GJ, de Waard JW. Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524 [Abstract] [Full Text] [Related]
3. Technetium-99m sestamibi scintimammography: the influence of histopathological characteristics, lesion size and the presence of carcinoma in situ in the detection of breast carcinoma. Howarth D, Sillar R, Clark D, Lan L. Eur J Nucl Med; 1999 Nov; 26(11):1475-81. PubMed ID: 10552090 [Abstract] [Full Text] [Related]
4. Breast cancer detection with 99m-Tc-sestamibi scintigraphy, mammography, and fine-needle aspiration cytology: comparative study in 64 surgically treated patients. Lumachi F, Marzola MC, Zucchetta P, Polistina F, Cagnato P, Favia G, Bui F. Ann Surg Oncol; 1999 Sep; 6(6):568-71. PubMed ID: 10493625 [Abstract] [Full Text] [Related]
5. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Vargas H, Jackson B, Klein S. J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043 [Abstract] [Full Text] [Related]
6. [99m Tc-MIBI scintigraphy compared to mammography in the diagnosis of breast cancer in dense, operated and young women breasts]. Mulero F, Nicolás F, Castellón MI, Fuentes T, de la Cruz P, Roca V, Abad L, Nuño de La Rosa JA. Rev Esp Med Nucl; 2000 Sep; 19(5):344-9. PubMed ID: 11062110 [Abstract] [Full Text] [Related]
7. Can scintimammography with (99m)Tc-MIBI identify multifocal and multicentric primary breast cancer? Cwikla JB, Buscombe JR, Holloway B, Parbhoo SP, Davidson T, McDermott N, Hilson AJ. Nucl Med Commun; 2001 Dec; 22(12):1287-93. PubMed ID: 11711898 [Abstract] [Full Text] [Related]
8. 99m Tc-sestamibi scintimammography in detection of recurrent breast cancer. Rajkovaca Z, Vuleta G, Matavulj A, Kovacević P, Ponorac N. Bosn J Basic Med Sci; 2007 Aug; 7(3):256-60. PubMed ID: 17848153 [Abstract] [Full Text] [Related]
9. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions. Fenlon HM, Phelan N, Tierney S, Gorey T, Ennis JT. Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430 [Abstract] [Full Text] [Related]
10. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer. Prats E, Aisa F, Abós MD, Villavieja L, García-López F, Asenjo MJ, Razola P, Banzo J. J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838 [Abstract] [Full Text] [Related]
11. Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy. Cwikla JB, Buscombe JR, Kelleher SM, Parbhoo SP, Thakrar DS, Hinton J, Deery AR, Crow J, Hilson AJ. Clin Radiol; 1998 Apr; 53(4):274-80. PubMed ID: 9585043 [Abstract] [Full Text] [Related]
12. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI. Sommer H, Tiling R, Pechmann M, Kindermann G, Kress K, Moser R, Tatsch K, Hahn K, Pfluger T, Assemi C. Zentralbl Gynakol; 1997 Apr; 119(1):6-11. PubMed ID: 9050197 [Abstract] [Full Text] [Related]
13. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts. Sun SS, Hsieh JF, Tsai SC, Ho YJ, Kao CH. Anticancer Res; 2000 Apr; 20(5C):3755-8. PubMed ID: 11268450 [Abstract] [Full Text] [Related]
14. Scintimammography with Tc-99m sestamibi. Khalkhali I, Iraniha S, Cutrone JA, Diggles LE, Klein SR. Acta Med Austriaca; 1997 Apr; 24(2):46-9. PubMed ID: 9227786 [Abstract] [Full Text] [Related]
15. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography. Papantoniou V, Tsiouris S, Mainta E, Valotassiou V, Souvatzoglou M, Sotiropoulou M, Nakopoulou L, Lazaris D, Louvrou A, Melissinou M, Tzannetaki A, Pirmettis I, Koutsikos J, Zerva C. Breast Cancer Res; 2005 Apr; 7(1):R33-45. PubMed ID: 15642168 [Abstract] [Full Text] [Related]
16. Comparative value of 99mTc-sestamibi scintimammography and sonography in the diagnostic workup of breast masses. Klaus AJ, Klingensmith WC, Parker SH, Stavros AT, Sutherland JD, Aldrete KD. AJR Am J Roentgenol; 2000 Jun; 174(6):1779-83. PubMed ID: 10845522 [Abstract] [Full Text] [Related]
17. The role of scintimammography with 99mTc-sestamibi as a complementary diagnostic technique in the detection of breast cancer. Danielsson R, Reihnér E, Grabowska A, Boné B. Acta Radiol; 2000 Sep; 41(5):441-5. PubMed ID: 11016763 [Abstract] [Full Text] [Related]
18. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions. Mekhmandarov S, Sandbank J, Cohen M, Lelcuk S, Lubin E. J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742 [Abstract] [Full Text] [Related]
19. Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography. Tolmos J, Cutrone JA, Wang B, Vargas HI, Stuntz M, Mishkin FS, Diggles LE, Venegas RJ, Klein SR, Khalkhali I. J Natl Cancer Inst; 1998 Jun 03; 90(11):846-9. PubMed ID: 9625173 [Abstract] [Full Text] [Related]
20. The initial Australian experience of technetium-99M sestamibi scintimammography: a complementary test in the management of breast cancer. Sillar R, Howarth D, Clark D. Aust N Z J Surg; 1997 Jul 03; 67(7):433-7. PubMed ID: 9236609 [Abstract] [Full Text] [Related] Page: [Next] [New Search]